Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from BONESUPPORT HOLDING AB ( (SE:BONEX) ) is now available.
BONESUPPORT has announced a significant leadership transition, with current CEO Emil Billbäck stepping down after 7.5 successful years to become a Senior Advisor. Torbjörn Sköld, with extensive experience in MedTech and a strong commercial track record, will take over as CEO on September 1, 2025. This change is expected to further bolster BONESUPPORT’s position as a fast-growing company in the orthobiologics sector, continuing its mission of transforming outdated standards of care through innovation.
More about BONESUPPORT HOLDING AB
BONESUPPORT is a prominent company in the orthobiologics industry, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes. These products are designed to remodel into the patient’s own bone and have the capability of eluting drugs. Based in Lund, Sweden, BONESUPPORT is recognized for its patented technology platform and conducts various clinical studies to demonstrate the clinical and health economic benefits of its products.
YTD Price Performance: -20.24%
Average Trading Volume: 361
Technical Sentiment Signal: Sell
Current Market Cap: $2.16B
For an in-depth examination of BONEX stock, go to TipRanks’ Stock Analysis page.